68.00
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $68.00, with a volume of 2.07M.
It is down -1.23% in the last 24 hours and down -0.12% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$68.85
Open:
$68.72
24h Volume:
2.07M
Relative Volume:
0.75
Market Cap:
$30.90B
Revenue:
$5.30B
Net Income/Loss:
$199.54M
P/E Ratio:
157.23
EPS:
0.4325
Net Cash Flow:
$1.24B
1W Performance:
-3.30%
1M Performance:
-0.12%
6M Performance:
+7.36%
1Y Performance:
+9.01%
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
VTR
Ventas Inc
|
68.00 | 31.29B | 5.30B | 199.54M | 1.24B | 0.4325 |
![]()
WELL
Welltower Inc
|
169.14 | 115.71B | 9.27B | 1.14B | 1.60B | 1.2106 |
![]()
DOC
Healthpeak Properties Inc
|
18.85 | 13.30B | 2.80B | 279.29M | 1.20B | 0.40 |
![]()
CTRE
Caretrust Reit Inc
|
33.99 | 7.70B | 219.54M | 99.24M | 205.68M | 0.72 |
![]()
AHR
American Healthcare Reit Inc
|
40.18 | 6.92B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
Sep-19-25 | Initiated | UBS | Neutral |
Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
Mar-07-25 | Upgrade | Argus | Hold → Buy |
Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-30-24 | Initiated | Deutsche Bank | Buy |
Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
Oct-03-23 | Initiated | Wedbush | Neutral |
Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
Apr-20-23 | Initiated | Wells Fargo | Overweight |
Nov-01-22 | Reiterated | Credit Suisse | Outperform |
Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
Jun-23-22 | Initiated | Credit Suisse | Outperform |
Jun-03-22 | Initiated | CapitalOne | Overweight |
May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
Feb-01-22 | Initiated | Credit Suisse | Neutral |
Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
Jul-14-21 | Resumed | Mizuho | Neutral |
Jun-15-21 | Initiated | Wolfe Research | Outperform |
Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
Jan-06-21 | Initiated | Robert W. Baird | Neutral |
Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
Sep-08-20 | Downgrade | Argus | Buy → Hold |
Sep-02-20 | Resumed | Stifel | Hold |
Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
Dec-20-19 | Resumed | Mizuho | Neutral |
Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
Nov-19-19 | Upgrade | Argus | Hold → Buy |
Oct-30-19 | Downgrade | Stifel | Buy → Hold |
Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas Announces Third Quarter 2025 Earnings Release Date and Conference Call - The Globe and Mail
Will Ventas Inc. stock maintain strong growth2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
Why Morningstar’s REIT Call Misses the Mark and the 8.4% Fund to Buy - Investing.com
Robeco Institutional Asset Management B.V. Sells 92,517 Shares of Ventas, Inc. $VTR - MarketBeat
Will Ventas Inc. (VEN) stock see valuation expansion2025 Price Targets & Weekly Stock Breakout Alerts - newser.com
Why Ventas Inc. stock attracts HNW investorsEarnings Miss & Safe Swing Trade Setups - newser.com
What earnings margins imply for Ventas Inc. stockJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
OLD National Bancorp IN Has $13.29 Million Stock Holdings in Ventas, Inc. $VTR - MarketBeat
How dovish Fed policy supports Ventas Inc. stockJuly 2025 Review & Accurate Intraday Trade Tips - newser.com
Stock Yards Bank & Trust Co. Has $823,000 Position in Ventas, Inc. $VTR - MarketBeat
Can Ventas Inc. stock surprise with quarterly resultsMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
Real time scanner hits for Ventas Inc. explainedJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
J. Safra Sarasin Holding AG Invests $1.85 Million in Ventas, Inc. $VTR - MarketBeat
Vanderbilt University Increases Stock Position in Ventas, Inc. $VTR - MarketBeat
U.S. Healthcare Real Estate Market is Going to Boom: Strategic - openPR.com
What Ventas (VTR)'s Latest Dividend Declaration Reveals About Its Commitment to Shareholder Returns - simplywall.st
Is Ventas Inc. stock undervalued at current priceGap Up & Daily Oversold Bounce Ideas - newser.com
Is Ventas Inc. forming a reversal patternTrade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
What does recent volatility data suggest for Ventas Inc.2025 Investor Takeaways & Growth Focused Stock Pick Reports - newser.com
BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $77 - 富途牛牛
Insider Sell Alert: Peter Bulgarelli Sells Shares of Ventas Inc (VTR) - GuruFocus
Ventas (NYSE:VTR) CEO Sells $142,779.60 in Stock - MarketBeat
Ventas (NYSE:VTR) CEO Debra Cafaro Sells 10,322 Shares - MarketBeat
Ventas (NYSE:VTR) Raised to "Strong-Buy" at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Investment Advisors L.P. Increases Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Shares Purchased by USA Financial Formulas - MarketBeat
UBS Initiates Coverage on Ventas (VTR) Citing SHOP Strength and AFFO Growth - Yahoo
Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance
Using economic indicators to assess Ventas Inc. potential2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
Cantor Fitzgerald initiates Ventas stock with Overweight rating on senior housing growth - Investing.com
Lbp Am Sa Buys 172,113 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas sells Issaquah senior community for over $38M - DJC
Ventas, Inc. Experiences Revision in Stock Evaluation Amid Positive Market Indicators - Markets Mojo
News | Ventas secures $475 million CMBS loan on Pennsylvania life sciences buildings - CoStar
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
Does Ventas' (VTR) Steady Dividend Reflect Strong Fundamentals or Limit Strategic Flexibility? - Yahoo Finance
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ventas Inc Stock (VTR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
CAFARO DEBRA A | Chairman and CEO |
Oct 01 '25 |
Sale |
70.24 |
10,322 |
724,986 |
1,145,695 |
Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS |
Oct 01 '25 |
Sale |
70.26 |
2,554 |
179,435 |
116,488 |
Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS |
Sep 30 '25 |
Sale |
69.99 |
2,040 |
142,780 |
119,042 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):